Mayo Clinic

The company's new privacy-preserving nSights platform accelerates the development of therapeutics and diagnostics for life sciences companies.

Mayo Clinic will onboard Triall's blockchain-integrated platform to embed verifiable data integrity into a pulmonary arterial hypertension trial

The new venture, called Safe Health Systems, aims to improve access to efficient, affordable treatment for common medical conditions.

The team will use AI analysis of ultrasound heart scans to identify the markers of heart failure and develop an image analysis risk prediction model.

Called Motion Medical, it aims to accelerate the development of medical technology and new minimally invasive treatments.

The two parties have teamed-up to develop tools for medical and non-medical personnel to easily screen for congenital long QT syndrome (LQTS) early.

Included in the deal are more than 4,000 comprehensive health topics spread across more than 18,000 pages of Mayo Clinic content.

Vitruvian Networks, will serve as a network orchestrator for therapeutic companies with powerful business intelligence and data analytics capabilities.

The quartet is working towards disrupting diabetes care delivery globally; the on-demand system is mobile-enabled, pain-free and extremely affordable.

The marketplace is a one-stop-shop to author, publish, and apply measures, allowing users to connect their data to open standard measure definitions.